Literature DB >> 2836633

Retroperitoneal lymphadenectomy for testis tumor with nerve sparing for ejaculation.

M A Jewett1, Y S Kong, S D Goldberg, J F Sturgeon, G M Thomas, R E Alison, M K Gospodarowicz.   

Abstract

The principal morbidity of retroperitoneal lymphadenectomy is the potential loss of ejaculation and, therefore, fertility owing to damage of the retroperitoneal sympathetic nerves that form the superior hypogastric plexus. We describe the results of our retroperitoneal lymphadenectomy when individual nerves from the sympathetic ganglia are identified and preserved while still performing a thorough bilateral retroperitoneal lymphadenectomy. The nerve-sparing procedure was technically feasible in 20 of 30 consecutive patients and it was only impractical with extensive gross disease. Of the 20 patients 18 (90 per cent) ejaculate, including 8 with bulky (5 cm. or more) residual retroperitoneal disease who underwent a successful nerve-sparing operation. All 12 patients (100 per cent) with nonbulky disease ejaculate. With short followup, no retroperitoneal recurrences have been detected. This technique is an alternative to limited dissection designed to spare nerves using boundaries based on the patterns of metastatic involvement.

Entities:  

Mesh:

Year:  1988        PMID: 2836633     DOI: 10.1016/s0022-5347(17)42869-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  32 in total

1.  [Retroperitoneal lymphadenectomy - pro laparoscopy].

Authors:  L Lusuardi; G Janetschek
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

2.  Retroperitoneal lymph node dissection for high-risk stage I and stage IIA seminoma.

Authors:  Zaza Mezvrishvili; Laurent Managadze
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 3.  The evolution, controversies, and potential pitfalls of modified retroperitoneal lymph node dissection templates.

Authors:  Mark H Katz; Scott E Eggener
Journal:  World J Urol       Date:  2009-04-11       Impact factor: 4.226

Review 4.  Reducing morbidity of pelvic and retroperitoneal lymphadenectomy.

Authors:  Mark W Ball; Michael A Gorin; Mohamad E Allaf
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

Review 5.  Critical evaluation of modified templates and current trends in retroperitoneal lymph node dissection.

Authors:  Shane Pearce; Zoe Steinberg; Scott Eggener
Journal:  Curr Urol Rep       Date:  2013-10       Impact factor: 3.092

6.  The total number of retroperitoneal lymph nodes resected impacts clinical outcome after chemotherapy for metastatic testicular cancer.

Authors:  Brett S Carver; Angel M Cronin; Scott Eggener; Caroline J Savage; Robert J Motzer; Dean Bajorin; George J Bosl; Joel Sheinfeld
Journal:  Urology       Date:  2010-03-17       Impact factor: 2.649

Review 7.  Physiology of the vas deferens.

Authors:  W D Steers
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 8.  Management of patients with low-stage nonseminomatous germ cell testicular cancer.

Authors:  Andrew J Stephenson; Joel Sheinfeld
Journal:  Curr Treat Options Oncol       Date:  2005-09

Review 9.  [When is surgical resection of metastases in testicular germ cell tumors indicated and is there a scientific basis?]

Authors:  A Heidenreich; P Paffenholz; F Haidl; D Pfister
Journal:  Urologe A       Date:  2017-05       Impact factor: 0.639

10.  High risk NSGCT: case for surveillance.

Authors:  David Michael Kakiashvili; Alvaro Zuniga; Michael A S Jewett
Journal:  World J Urol       Date:  2009-07-16       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.